title: Pretreatment growth rate as a predictor of tumor control following Gamma Knife radiosurgery for sporadic vestibular schwannoma.
abstract: OBJECTIVE Over the last 30 years, stereotactic radiosurgery (SRS) has become an established noninvasive treatment alternative for small- to medium-sized vestibular schwannoma (VS). This study aims to further define long-term SRS tumor control in patients with documented pretreatment tumor growth for whom conservative observation failed. METHODS A prospective clinical database was queried, and patients with sporadic VS who elected initial observation and subsequently underwent SRS after documented tumor growth between 2004 and 2014 were identified. Posttreatment tumor growth or shrinkage was determined by a ≥ 2-mm increase or decrease in maximum linear dimension, respectively. RESULTS Sixty-eight patients met study inclusion criteria. The median pre- and posttreatment observation periods were 16 and 43.5 months, respectively. The median dose to the tumor margin was 13 Gy (range 12-14 Gy), and the median maximum dose was 26 Gy (range 24-28 Gy). At the time of treatment, 59 tumors exhibited extracanalicular (EC) extension, and 9 were intracanalicular (IC). Of the 59 EC VSs, 50 (85%) remained stable or decreased in size following treatment, and 9 (15%) enlarged by > 2 mm. Among EC tumors, the median pretreatment tumor growth rate was 2.08 mm/year for tumors that decreased or were stable, compared with 3.26 mm/year for tumors that grew following SRS (p = 0.009). Patients who demonstrated a pretreatment growth rate of < 2.5 mm/year exhibited a 97% tumor control rate, compared with 69% for those demonstrating ≥ 2.5 mm/year of growth prior to SRS (p = 0.007). No other analyzed variables were found to predict tumor growth following SRS. CONCLUSIONS Overall, SRS administered using a marginal dose between 12-14 Gy is highly effective in treating VSs in which initial observation fails. Tumor control is achieved in 97% of VSs that exhibit slow (< 2.5 mm/year) pretreatment growth; however, SRS is less successful in treating tumors exhibiting rapid growth (≥ 2.5 mm/year).
authors.affiliation: Departments of 1 Otolaryngology-Head and Neck Surgery.
authors.forename: Alexander P
authors.initials: AP
authors.lastname: Marston
authors.affiliation: Neurologic Surgery, and.
authors.forename: Jeffrey T
authors.initials: JT
authors.lastname: Jacob
authors.affiliation: Departments of 1 Otolaryngology-Head and Neck Surgery.
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Carlson
authors.affiliation: Neurologic Surgery, and.|Radiation Oncology, Mayo Clinic School of Medicine, Rochester, Minnesota.
authors.forename: Bruce E
authors.initials: BE
authors.lastname: Pollock
authors.affiliation: Departments of 1 Otolaryngology-Head and Neck Surgery.|Neurologic Surgery, and.
authors.forename: Colin L W
authors.initials: CLW
authors.lastname: Driscoll
authors.affiliation: Departments of 1 Otolaryngology-Head and Neck Surgery.|Neurologic Surgery, and.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Link
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D049109:Cell Proliferation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009464:Neuroma, Acoustic / Q000473:pathology* / Q000532:radiotherapy*; D011379:Prognosis; D011446:Prospective Studies; D016634:Radiosurgery; D016896:Treatment Outcome; D047368:Tumor Burden; D055815:Young Adult
keywords: AAO-HNS = American Academy of Otolaryngology–Head and Neck Surgery; EC = extracanalicular; GKS = Gamma Knife radiosurgery; Gamma Knife radiosurgery; IC = intracanalicular; IQR = interquartile range; SRS = stereotactic radiosurgery; VS = vestibular schwannoma; acoustic neuroma; stereotactic radiosurgery; vestibular schwannoma